• E-mail :[email]
  • Phone : +33 6 23 08 96 35
  • Location : Grenoble, France
Last update 2011-05-10 17:39:55.829

Laurent Riou PhD in Cellular Biology

Course and current status

Qualifications :

PhD in Cellular Biology, Grenoble University, 1999

HDR, Habilitation à Diriger des Recherches (Habilitation to Supervise Research), Grenoble University, 2006


Present Post :

Assistant Research Professor (CR1), INSERM, U1039, Radiopharmaceutiques Biocliniques, Grenoble, France


Past Positions:

2007-present : Assistant Research Professor (CR1), INSERM U1039, Radiopharmaceutiques Biocliniques, Grenoble, France

2003-2007 : Assistant Research Professor (CR2), INSERM E0008, Radiopharmaceutiques Biocliniques, Grenoble, France

1999-2003 : Post-docotoral fellow, Experimental NUclear Cardiology Laboratory, University of Viginia, Charlottesville, VA, USA

1996-99 : PhD student, Laboratoire d'Etudes de Radiopharmaceutiques, ESA CNRS 5077 / LRC CEA 10, Grenoble, France

Scientific summary

Our field of research relates to nuclear imaging and cardiovascular diseases. More specifically, our main objective is to develop new nuclear imaging agents for the early non invasive diagnosis and prognosis of cardiovascular conditions. Our initial PhD and post-doc work was focused on experimental studies on new myocardial perfusion and inflammation imaging agents for the non invasive diagnosis and prognosis of coronary artery disease. More recently, we worked on the experimental evaluation of potentially interesting novel agents for the molecular imaging of vulnerable atherosclerotic plaques for the identification of individual at high cardiovascular risk prior to the occurrence of a coronary event. Among those, the tracer 99mTc-B2702p1 will be clinically evaluated in the near future (ANR grant PLAQUIMAG). Another important area of interest relate to the non invasive assessment of coronary microvasculature using an original analysis of clinical and small animal nuclear perfusion images. We are also interested in the development and experimental validation of novel radiolabeling methodologies as well as new small animal imaging equipment through academic collaborations.

Image d’exemple